Intersect ENT Inc logo

Intersect ENT Inc

(Delisted) $ 28.24 0 (0%) 09:40 AM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 954.90M
Enterprise V:
$ 1.06B
Volume:
-
Avg Vol (2M):
600.19K
Also Trade In:
Volume:
-
Market Cap $:
954.90M
PE Ratio:
At Loss
Avg Vol (2-Month):
600.19K
Enterprise Value $:
1.06B
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Intersect ENT Inc
NAICS : 339112 SIC : 3841
1555 Adams Drive, Menlo Park, CA, USA, 94025
Compare
Compare
VREX TMCI KIDS CERS HSKA OM SILK CUTR ATEC TMDX ABT MDT SYK EW BSX SZSE:300760 DXCM ZBH STE ALGN
Traded in other countries / regions
7IN.Germany XENT.USA
Description
Intersect ENT Inc are a commercial drug delivery company committed to improving the quality of life for patients with ear, nose and throat conditions. It offer's PROPEL and PROPEL mini drug-releasing implants for patients undergoing sinus surgery to treat chronic sinusitis and PROPEL contour, a steroid-releasing implant to frontal and maxillary sinus ostia or openings of the dependent sinuses. The company generates revenues from the sale of our PROPEL family of products.
Name Current Vs Industry Vs History
Cash-To-Debt 0.32
Equity-to-Asset -0.74
Debt-to-Equity -1.68
Debt-to-EBITDA -0.99
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.82
Distress
Grey
Safe
Beneish M-Score -3.96
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 78.92
9-Day RSI 69.25
14-Day RSI 64.96
6-1 Month Momentum % 3.17
12-1 Month Momentum % 56.28

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.88
Quick Ratio 1.5
Cash Ratio 1.09
Days Inventory 211.33
Days Sales Outstanding 53.02
Days Payable 107.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3

Financials (Next Earnings Date:2022-11-02 Est.)

XENT's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:XENT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 103.995
EPS (TTM) ($) -5.04
Beta 0
Volatility % 45.54
14-Day RSI 64.96
14-Day ATR ($) 0.184988
20-Day SMA ($) 27.92
12-1 Month Momentum % 56.28
52-Week Range ($) 15.92 - 28.25
Shares Outstanding (Mil) 33.81

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Intersect ENT Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More